Topically Applied Ethanol Extract of Ecklonia stolonifera Okamura Ameliorates DNFB-Induced Allergic Contact Dermatitis in Mice

Background and Objectives: Contact dermatitis (CD) represents a prevalent cutaneous inflammatory disorder manifesting as localized redness and swelling, accompanied pathologically by microstructural epidermal damage and leukocyte extravasation. Given the clinical limitations and cutaneous complications linked to extended glucocorticoid therapy, identifying safe, non-steroidal therapeutic alternatives remains an urgent objective. Here, we explored the anti-dermatitic efficacy of a 70% ethanolic preparation obtained from the brown seaweed Ecklonia stolonifera Okamura (EEES) using BALB/c mice challenged with 2,4-dinitrofluorobenzene (DNFB). Materials and Methods: Following sensitization and elicitation, animals received topical EEES at daily doses of 60, 180, or 600 μg, while dexamethasone served as the benchmark intervention. Macroscopic damage severity, photometrically recorded cutaneous erythema and spectrophotometrically assessed melanin indices, cutaneous tissue mass, microarchitectural tissue disruptions, immune cell accumulation, inflammatory signaling molecules, and somatic/splenic weight alterations were thoroughly quantified. Results: Cutaneous administration of 600 μg/day EEES, as well as dexamethasone, led to marked reductions in gross lesion scores and skin tissue weight relative to untreated DNFB-insulted controls. Treatment with EEES consistently suppressed cutaneous redness, ameliorated microarchitectural lesions, and curbed leukocyte infiltration into lesional sites. At the molecular level, EEES downregulated key pro-inflammatory mediators (TNF-α, IFN-γ, and IL-6), whereas DNFB-evoked MCP-1 production remained largely uninhibited. Notably, systemic indicators including normalized body mass gain and splenic somatic index were unaffected by EEES under the tested regimen. Conclusions: Topically administered EEES effectively alleviates cutaneous hypersensitivity and allergic manifestations in DNFB-elicited allergic CD, predominantly through the suppression of localized pro-inflammatory signaling cascades.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-11-19
DOI
https://doi.org/10.3390/medicina62112271
Primary Topic
Contact Dermatitis and Allergies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Topically Applied Ethanol Extract of Ecklonia stolonifera Okamura Ameliorates DNFB-Induced Allergic Contact Dermatitis in Mice

Han-Sol Jeong, Jinhu Peng, Yeojin Kim, 장지녕 et al.
Medicina
Contact Dermatitis and Allergies
article

Topically Applied Ethanol Extract of Ecklonia stolonifera Okamura Ameliorates DNFB-Induced Allergic Contact Dermatitis in Mice

Han-Sol Jeong, Jinhu Peng, Yeojin Kim, 장지녕, Hyungwoo Kim, Jimi Lee, Soyeon Kim, Seungju Park, Hyorhan Son
article en

Abstract

Background and Objectives: Contact dermatitis (CD) represents a prevalent cutaneous inflammatory disorder manifesting as localized redness and swelling, accompanied pathologically by microstructural epidermal damage and leukocyte extravasation. Given the clinical limitations and cutaneous complications linked to extended glucocorticoid therapy, identifying safe, non-steroidal therapeutic alternatives remains an urgent objective. Here, we explored the anti-dermatitic efficacy of a 70% ethanolic preparation obtained from the brown seaweed Ecklonia stolonifera Okamura (EEES) using BALB/c mice challenged with 2,4-dinitrofluorobenzene (DNFB). Materials and Methods: Following sensitization and elicitation, animals received topical EEES at daily doses of 60, 180, or 600 μg, while dexamethasone served as the benchmark intervention. Macroscopic damage severity, photometrically recorded cutaneous erythema and spectrophotometrically assessed melanin indices, cutaneous tissue mass, microarchitectural tissue disruptions, immune cell accumulation, inflammatory signaling molecules, and somatic/splenic weight alterations were thoroughly quantified. Results: Cutaneous administration of 600 μg/day EEES, as well as dexamethasone, led to marked reductions in gross lesion scores and skin tissue weight relative to untreated DNFB-insulted controls. Treatment with EEES consistently suppressed cutaneous redness, ameliorated microarchitectural lesions, and curbed leukocyte infiltration into lesional sites. At the molecular level, EEES downregulated key pro-inflammatory mediators (TNF-α, IFN-γ, and IL-6), whereas DNFB-evoked MCP-1 production remained largely uninhibited. Notably, systemic indicators including normalized body mass gain and splenic somatic index were unaffected by EEES under the tested regimen. Conclusions: Topically administered EEES effectively alleviates cutaneous hypersensitivity and allergic manifestations in DNFB-elicited allergic CD, predominantly through the suppression of localized pro-inflammatory signaling cascades.

MedicinaVol. 62(11)
Pusan National University (KR)
Contact Dermatitis and Allergies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon